CA3042629A1 - Detection amelioree de changements de fluide - Google Patents
Detection amelioree de changements de fluide Download PDFInfo
- Publication number
- CA3042629A1 CA3042629A1 CA3042629A CA3042629A CA3042629A1 CA 3042629 A1 CA3042629 A1 CA 3042629A1 CA 3042629 A CA3042629 A CA 3042629A CA 3042629 A CA3042629 A CA 3042629A CA 3042629 A1 CA3042629 A1 CA 3042629A1
- Authority
- CA
- Canada
- Prior art keywords
- patient
- vips
- fluid
- receiver
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 226
- 238000001514 detection method Methods 0.000 title description 34
- 230000001976 improved effect Effects 0.000 title description 6
- 230000010363 phase shift Effects 0.000 claims abstract description 125
- 210000005069 ears Anatomy 0.000 claims abstract description 17
- 238000004611 spectroscopical analysis Methods 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 120
- 210000004556 brain Anatomy 0.000 claims description 111
- 230000008859 change Effects 0.000 claims description 67
- 210000004369 blood Anatomy 0.000 claims description 58
- 239000008280 blood Substances 0.000 claims description 58
- 230000033001 locomotion Effects 0.000 claims description 35
- 230000005856 abnormality Effects 0.000 claims description 17
- 238000012545 processing Methods 0.000 description 90
- 238000005259 measurement Methods 0.000 description 69
- 210000003128 head Anatomy 0.000 description 62
- 230000000747 cardiac effect Effects 0.000 description 55
- 238000007917 intracranial administration Methods 0.000 description 52
- 210000001519 tissue Anatomy 0.000 description 51
- 238000012544 monitoring process Methods 0.000 description 47
- 230000005540 biological transmission Effects 0.000 description 34
- 238000005070 sampling Methods 0.000 description 32
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 29
- 230000000694 effects Effects 0.000 description 20
- 239000003381 stabilizer Substances 0.000 description 20
- 206010030113 Oedema Diseases 0.000 description 19
- 208000006011 Stroke Diseases 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- 206010010254 Concussion Diseases 0.000 description 17
- 230000009514 concussion Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 230000004044 response Effects 0.000 description 17
- 239000000523 sample Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 238000005516 engineering process Methods 0.000 description 16
- 230000017531 blood circulation Effects 0.000 description 15
- 238000004891 communication Methods 0.000 description 15
- 125000006850 spacer group Chemical group 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 12
- 208000032843 Hemorrhage Diseases 0.000 description 11
- 230000008901 benefit Effects 0.000 description 11
- 208000029028 brain injury Diseases 0.000 description 11
- 238000010586 diagram Methods 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 230000000740 bleeding effect Effects 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 9
- 239000004020 conductor Substances 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 230000002747 voluntary effect Effects 0.000 description 9
- 238000012935 Averaging Methods 0.000 description 8
- 208000006752 brain edema Diseases 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 208000028867 ischemia Diseases 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000007333 Brain Concussion Diseases 0.000 description 7
- 206010048962 Brain oedema Diseases 0.000 description 7
- 230000002490 cerebral effect Effects 0.000 description 7
- 230000006835 compression Effects 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 210000000056 organ Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000002106 pulse oximetry Methods 0.000 description 7
- 210000003625 skull Anatomy 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 208000019695 Migraine disease Diseases 0.000 description 6
- 230000010455 autoregulation Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000002680 cardiopulmonary resuscitation Methods 0.000 description 6
- 230000001427 coherent effect Effects 0.000 description 6
- 230000002596 correlated effect Effects 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 238000002565 electrocardiography Methods 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 6
- 210000004731 jugular vein Anatomy 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010007559 Cardiac failure congestive Diseases 0.000 description 5
- 206010019280 Heart failures Diseases 0.000 description 5
- 206010070995 Vascular compression Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010027599 migraine Diseases 0.000 description 5
- 230000006855 networking Effects 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000032382 Ischaemic stroke Diseases 0.000 description 4
- 206010025282 Lymphoedema Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 208000034158 bleeding Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 210000005013 brain tissue Anatomy 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000013480 data collection Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 4
- 210000001061 forehead Anatomy 0.000 description 4
- 208000000122 hyperventilation Diseases 0.000 description 4
- 230000000870 hyperventilation Effects 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 208000002502 lymphedema Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 3
- 206010019196 Head injury Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 3
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000006880 cross-coupling reaction Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 210000002977 intracellular fluid Anatomy 0.000 description 3
- 238000007914 intraventricular administration Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 238000011176 pooling Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229960000187 tissue plasminogen activator Drugs 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000008321 arterial blood flow Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000008499 blood brain barrier function Effects 0.000 description 2
- 210000001218 blood-brain barrier Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- 230000010351 cardiac pulsation Effects 0.000 description 2
- 238000007675 cardiac surgery Methods 0.000 description 2
- 210000001715 carotid artery Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000008867 communication pathway Effects 0.000 description 2
- 206010010121 compartment syndrome Diseases 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003989 dielectric material Substances 0.000 description 2
- 238000005553 drilling Methods 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 238000002692 epidural anesthesia Methods 0.000 description 2
- 230000009986 erectile function Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000002008 hemorrhagic effect Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006322 Breath holding Diseases 0.000 description 1
- 206010007687 Carotid artery stenosis Diseases 0.000 description 1
- 206010051290 Central nervous system lesion Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 241001503987 Clematis vitalba Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010059256 Dialysis disequilibrium syndrome Diseases 0.000 description 1
- 206010063395 Dural tear Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 238000004497 NIR spectroscopy Methods 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 208000004717 Ruptured Aneurysm Diseases 0.000 description 1
- 206010062243 Shunt malfunction Diseases 0.000 description 1
- 206010041273 Sodium imbalance Diseases 0.000 description 1
- 102000005393 Sodium-Potassium-Exchanging ATPase Human genes 0.000 description 1
- 108010006431 Sodium-Potassium-Exchanging ATPase Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000035581 baroreflex Effects 0.000 description 1
- 210000001841 basilar artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004903 cardiac system Anatomy 0.000 description 1
- 208000006170 carotid stenosis Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000000537 electroencephalography Methods 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 230000002518 glial effect Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000000076 hypertonic saline solution Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 238000001690 micro-dialysis Methods 0.000 description 1
- 210000003657 middle cerebral artery Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000010984 neurological examination Methods 0.000 description 1
- 230000003557 neuropsychological effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- -1 phagocyte cells Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 208000037974 severe injury Diseases 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002693 spinal anesthesia Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Detecting, measuring or recording fluid pressure within the body other than blood pressure, e.g. cerebral pressure; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- General Business, Economics & Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
L'invention concerne un dispositif de spectroscopie de déphasage intégrale volumétrique (VIPS) pour détecter une preuve d'un accident vasculaire cérébral chez un patient, pouvant comprendre un cadre comprenant un boîtier, au moins un récepteur VIPS dans le boîtier, des circuits dans le boîtier couplés à l'au moins un récepteur VIPS, deux extrémités enveloppantes, configurées pour s'enrouler autour de l'arrière de la tête du patient et sur les oreilles, un premier émetteur VIPS dans l'une des deux extrémités enroulées, un second émetteur VIPS dans l'autre des deux extrémités enroulées, et un processeur. Les premier et second émetteurs VIPS et l'au moins un récepteur VIPS peuvent mesurer de multiples déphasages et/ou de multiples amplitudes dans un fluide et/ou un tissu dans la tête du patient. Le processeur peut déterminer que les multiples déphasages et/ou les multiples amplitudes correspondent à une signature VIPS prédéfinie spécifique à un accident vasculaire cérébral et détecter ainsi une preuve d'un accident vasculaire cérébral.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/349,260 | 2016-11-11 | ||
| US15/349,260 US20170055839A1 (en) | 2013-01-18 | 2016-11-11 | Detection of fluid changes |
| PCT/US2016/069209 WO2018089035A1 (fr) | 2016-11-11 | 2016-12-29 | Détection améliorée de changements de fluide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3042629A1 true CA3042629A1 (fr) | 2018-05-17 |
Family
ID=62110676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3042629A Abandoned CA3042629A1 (fr) | 2016-11-11 | 2016-12-29 | Detection amelioree de changements de fluide |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3537951A4 (fr) |
| JP (1) | JP2020511173A (fr) |
| CN (1) | CN110191672A (fr) |
| AU (1) | AU2016429442A1 (fr) |
| CA (1) | CA3042629A1 (fr) |
| IL (1) | IL266498A (fr) |
| MA (1) | MA46734A (fr) |
| WO (1) | WO2018089035A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220125323A1 (en) * | 2019-01-17 | 2022-04-28 | The Regents Of The University Of California | Systems, devices, and methods for detecting brain conditions from cranial movement due to blood flow in the brain |
| US11401542B2 (en) * | 2019-10-23 | 2022-08-02 | National Tsing Hua University | Acoustically actuated droplet apparatus and a chemical analysis method by using acoustically actuated droplet |
| CN111736523B (zh) * | 2020-06-23 | 2022-11-29 | 吉林省科英激光股份有限公司 | 一种可实现扫描电机零点位置补偿的控制系统及方法 |
| CN113300085A (zh) * | 2021-05-25 | 2021-08-24 | 安徽大学 | 一种面向3g/4g/5g小型宽带双极化基站天线单元 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006135520A1 (fr) * | 2005-06-09 | 2006-12-21 | The Regents Of The University Of California | Systeme de detection volumetrique de dephasage d'induction permettant de determiner les proprietes de teneur en eau d'un tissu |
| US20080177163A1 (en) * | 2007-01-19 | 2008-07-24 | O2 Medtech, Inc. | Volumetric image formation from optical scans of biological tissue with multiple applications including deep brain oxygenation level monitoring |
| US20110201950A1 (en) * | 2008-10-07 | 2011-08-18 | Orsan Medical Technologies Ltd. | Monitoring of acute stroke patients |
| US8613714B2 (en) * | 2010-10-05 | 2013-12-24 | Cerevast Therapeutics, Inc. | Non-invasive transcranial ultrasound apparatus |
| US20120203121A1 (en) * | 2011-02-09 | 2012-08-09 | Opher Kinrot | Devices and methods for monitoring cerebral hemodynamic characteristics |
| US8303110B1 (en) * | 2011-09-11 | 2012-11-06 | Google Inc. | Nose pads for a wearable device having an electrically-controllable hardness |
| CA2863449C (fr) * | 2012-01-19 | 2019-07-02 | Cerebrotech Medical Systems, Inc. | Systeme de diagnostic pour detecter des changements dans un fluide |
| JP6028357B2 (ja) * | 2012-03-22 | 2016-11-16 | ソニー株式会社 | ヘッドマウントディスプレイ及び手術システム |
| US20160007879A1 (en) * | 2013-03-15 | 2016-01-14 | The Regents Of The University Of California | Multifrequency signal processing classifiers for determining a tissue condition |
| EP2983583A2 (fr) * | 2013-04-12 | 2016-02-17 | Orsan Medical Technologies, Ltd. | Mesure de paramètres physiologiques cérébraux en utilisant la bioimpédance |
| WO2015106180A1 (fr) * | 2014-01-10 | 2015-07-16 | Marcio Marc Abreu | Dispositifs pour surveiller et appliquer un traitement au niveau d'un tunnel cérébral abreu |
| JP2016515404A (ja) * | 2014-03-15 | 2016-05-30 | ニューロライフ リミテッド | 医学的状態の治療および評価のためのヘッドセット |
| EP3188653B1 (fr) * | 2014-09-03 | 2021-06-23 | Cerebrotech Medical Systems, Inc. | Appareil pour la détection et analyse de niveaux de fluide variant spatialement au moyen de signaux magnétiques |
-
2016
- 2016-12-29 JP JP2019524411A patent/JP2020511173A/ja active Pending
- 2016-12-29 AU AU2016429442A patent/AU2016429442A1/en not_active Abandoned
- 2016-12-29 CA CA3042629A patent/CA3042629A1/fr not_active Abandoned
- 2016-12-29 CN CN201680091869.9A patent/CN110191672A/zh active Pending
- 2016-12-29 WO PCT/US2016/069209 patent/WO2018089035A1/fr unknown
- 2016-12-29 EP EP16921385.7A patent/EP3537951A4/fr not_active Withdrawn
- 2016-12-29 MA MA046734A patent/MA46734A/fr unknown
-
2019
- 2019-05-07 IL IL266498A patent/IL266498A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3537951A1 (fr) | 2019-09-18 |
| JP2020511173A (ja) | 2020-04-16 |
| AU2016429442A1 (en) | 2019-05-23 |
| CN110191672A (zh) | 2019-08-30 |
| WO2018089035A1 (fr) | 2018-05-17 |
| MA46734A (fr) | 2019-09-18 |
| EP3537951A4 (fr) | 2020-07-01 |
| IL266498A (en) | 2019-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11723597B2 (en) | Detection and analysis of spatially varying fluid levels using magnetic signals | |
| US11357417B2 (en) | Continuous autoregulation system | |
| EP3188653B1 (fr) | Appareil pour la détection et analyse de niveaux de fluide variant spatialement au moyen de signaux magnétiques | |
| US20170055839A1 (en) | Detection of fluid changes | |
| US20170319099A1 (en) | Continuous fluid monitoring system | |
| US11612331B2 (en) | Headset device for detecting fluid in cranium via time varying magnetic field phase shifts and harmonics of fundamental frequencies | |
| CA3082344A1 (fr) | Systeme d'autoregulation continue | |
| CA3042629A1 (fr) | Detection amelioree de changements de fluide | |
| CN112998685B (en) | Detecting and analyzing spatially varying fluid levels using magnetic signals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20230321 |
|
| FZDE | Discontinued |
Effective date: 20230321 |